A complete understanding of therapy resistance requires functional interrogation of the biological ecosystem using interdisciplinary science.
Welcome, and thanks for visiting our website!
Our team is dedicated to unmasking the mechanisms that drive response and resistance to conventional and immuno-modulatory drugs for multiple diseases including cancer and neuro-psychiatry. Importantly, we also seek to provide immediate solutions in the clinic.
Our research lies at the forefront of innovation, integrating a unique interdisciplinary tool set including biology, mathematics, next-generation sequencing and bioengineering approaches. We also place a special emphasis on building an academic, integrated atmosphere culturing our future generation of successful scientists.
RECENT NEWS
August, 2024: Strategic Partnership and Sponsorship with Pluristyx Inc.
Aaron Goldman Builds Bridges to Advance Drug Development
March, 2023: New research article
December, 2021: New research article
July, 2021: Funding